Quarterlytics / Healthcare / Biotechnology / LB Pharmaceuticals Inc Common Stock

LB Pharmaceuticals Inc Common Stock

LBRX · NASDAQ Healthcare
Claim this profile
Ticker LBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Employees 16
Overview Research & Coverage Annual Reports FAQ Peers Earnings Calls Financials News Management

Business description

Clinical‑stage biopharmaceutical company developing novel therapies for neuropsychiatric diseases (e.g. schizophrenia, bipolar depression). Lead candidate is LB‑102, a methylated derivative of amisulpride.

New York, NY
Is this your company?
Claim profile to control your coverage, no call required.
Company facts
TickerLBRX
ExchangeNASDAQ
Sector Healthcare
Industry Biotechnology
Employees16